Erratum: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (Nature medicine (2000) 6 (1167-1175))

B. Bielekova; B. Goodwin; N. Richert; I. Cortese; T. Kondo; G. Afshar; B. Gran; J. Eaton; J. Antel; J. A. Frank; H. F. McFarland; R. Martin

doi:10.1038/82242

Erratum: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (Nature medicine (2000) 6 (1167-1175))

B. Bielekova, B. Goodwin, N. Richert, I. Cortese, T. Kondo, G. Afshar, B. Gran, J. Eaton, J. Antel, J. A. Frank, H. F. McFarland, R. Martin

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1412
Number of pages	1
Journal	Nature Medicine
Volume	6
Issue number	12
DOIs	https://doi.org/10.1038/82242
State	Published - 2000
Externally published	Yes

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology
General Medicine

Access to Document

10.1038/82242

Cite this

Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., McFarland, H. F., & Martin, R. (2000). Erratum: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (Nature medicine (2000) 6 (1167-1175)). Nature Medicine, 6(12), 1412. https://doi.org/10.1038/82242

Erratum: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (Nature medicine (2000) 6 (1167-1175)). / Bielekova, B.; Goodwin, B.; Richert, N. et al.
In: Nature Medicine, Vol. 6, No. 12, 2000, p. 1412.

Research output: Contribution to journal › Article › peer-review

Bielekova, B, Goodwin, B, Richert, N, Cortese, I, Kondo, T, Afshar, G, Gran, B, Eaton, J, Antel, J, Frank, JA, McFarland, HF & Martin, R 2000, 'Erratum: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (Nature medicine (2000) 6 (1167-1175))', Nature Medicine, vol. 6, no. 12, pp. 1412. https://doi.org/10.1038/82242

@article{f872fec5301b4993b6269ad964a669b4,

title = "Erratum: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (Nature medicine (2000) 6 (1167-1175))",

author = "B. Bielekova and B. Goodwin and N. Richert and I. Cortese and T. Kondo and G. Afshar and B. Gran and J. Eaton and J. Antel and Frank, {J. A.} and McFarland, {H. F.} and R. Martin",

year = "2000",

doi = "10.1038/82242",

language = "English (US)",

volume = "6",

pages = "1412",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Erratum

T2 - Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (Nature medicine (2000) 6 (1167-1175))

AU - Bielekova, B.

AU - Goodwin, B.

AU - Richert, N.

AU - Cortese, I.

AU - Kondo, T.

AU - Afshar, G.

AU - Gran, B.

AU - Eaton, J.

AU - Antel, J.

AU - Frank, J. A.

AU - McFarland, H. F.

AU - Martin, R.

PY - 2000

Y1 - 2000

UR - http://www.scopus.com/inward/record.url?scp=0034533320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034533320&partnerID=8YFLogxK

U2 - 10.1038/82242

DO - 10.1038/82242

M3 - Article

C2 - 11100131

AN - SCOPUS:0034533320

SN - 1078-8956

VL - 6

SP - 1412

JO - Nature Medicine

JF - Nature Medicine

IS - 12

ER -

Erratum: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (Nature medicine (2000) 6 (1167-1175))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this